Cargando…
Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53‐associated features
TP53 gene mutations are very common in human cancer. While such mutations abrogate the tumor suppressive activities of the wild‐type (wt) p53 protein, some of them also endow the mutant (mut) protein with oncogenic gain of function (GOF), facilitating cancer progression. Yet, p53 may acquire altered...
Autores principales: | Benor, Gal, Fuks, Garold, Chin, Suet‐Feung, Rueda, Oscar M., Mukherjee, Saptaparna, Arandkar, Sharathchandra, Aylon, Yael, Caldas, Carlos, Domany, Eytan, Oren, Moshe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400784/ https://www.ncbi.nlm.nih.gov/pubmed/32484602 http://dx.doi.org/10.1002/1878-0261.12736 |
Ejemplares similares
-
Down-regulation of LATS kinases alters p53 to promote cell migration
por: Furth, Noa, et al.
Publicado: (2015) -
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins
por: Mukherjee, Saptaparna, et al.
Publicado: (2022) -
TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts
por: Kucab, Jill E., et al.
Publicado: (2015) -
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
por: Abrams, Stephen L., et al.
Publicado: (2022) -
Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation
por: Aylon, Yael, et al.
Publicado: (2009)